629 related articles for article (PubMed ID: 10602468)
1. Aberrant rel/nfkb genes and activity in human cancer.
Rayet B; Gélinas C
Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
[TBL] [Abstract][Full Text] [Related]
2. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
[TBL] [Abstract][Full Text] [Related]
3. Rel/NF-kappa B and I kappa B factors in oncogenesis.
Luque I; Gélinas C
Semin Cancer Biol; 1997 Apr; 8(2):103-11. PubMed ID: 9299588
[TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
5. To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis.
Kucharczak J; Simmons MJ; Fan Y; Gélinas C
Oncogene; 2003 Dec; 22(56):8961-82. PubMed ID: 14663476
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
7. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
8. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views.
Chen FE; Ghosh G
Oncogene; 1999 Nov; 18(49):6845-52. PubMed ID: 10602460
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity.
Finn PW; He H; Ma C; Mueller T; Stone JR; Liou HC; Boothby MR; Perkins DL
J Leukoc Biol; 2002 Nov; 72(5):1054-62. PubMed ID: 12429729
[TBL] [Abstract][Full Text] [Related]
10. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract][Full Text] [Related]
11. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
12. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
[TBL] [Abstract][Full Text] [Related]
13. The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription.
Mosialos G
Semin Cancer Biol; 1997 Apr; 8(2):121-9. PubMed ID: 9299590
[TBL] [Abstract][Full Text] [Related]
14. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
15. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
Fan Y; Rayet B; Gélinas C
Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
[TBL] [Abstract][Full Text] [Related]
16. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
17. The c-Rel transcription factor and B-cell proliferation: a deal with the devil.
Gilmore TD; Kalaitzidis D; Liang MC; Starczynowski DT
Oncogene; 2004 Mar; 23(13):2275-86. PubMed ID: 14755244
[TBL] [Abstract][Full Text] [Related]
18. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
Epinat JC; Gilmore TD
Oncogene; 1999 Nov; 18(49):6896-909. PubMed ID: 10602465
[TBL] [Abstract][Full Text] [Related]
19. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation.
Hanson JL; Hawke NA; Kashatus D; Baldwin AS
Cancer Res; 2004 Oct; 64(20):7248-55. PubMed ID: 15492243
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB in cancer--a friend turned foe.
Ravi R; Bedi A
Drug Resist Updat; 2004 Feb; 7(1):53-67. PubMed ID: 15072771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
